Pleconaril and Ribavirin in New-Onset Type 1 Diabetes: A Phase II Randomized Trial

In a phase II, placebo-controlled, randomized, parallel group, double-blind trial, 96 children and adolescents with new-onset T1D received antiviral treatment with pleconaril and ribavirin or placebo for six months, with the aim of preserving β cell function.